Open AccessSuccessful treatment of chronic hepatitis C in a hemodialysis
Author(s) -
Ivana Milošević,
Uroš Karić,
Ivana Pešić-Pavlović,
Goran Stevanović,
Aleksandra Barać,
Marijana Smiljanić,
Aleksandra Arsenović,
Oliver Stevanović́,
Miljana Đonin-Nenezić,
Branko Brmbolić
Publication year - 2018
Publication title -
journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.10257
Subject(s) - dasabuvir , ombitasvir , ribavirin , medicine , hemodialysis , paritaprevir , chronic hepatitis , ritonavir , hepatitis c , intensive care medicine , virology , viral load , virus , antiretroviral therapy
We present the first case of successful direct acting antiviral therapy of chronic hepatitis C in a hemodialysis patient in Serbia. The patient infected with genotype 1a has been successfully treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ribavirin. There are only a few real world reports regarding this therapeutic option in hemodialysis patients.